Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Compliance/Legal Officer
-
Stock Symbol
-
CPRX on Nasdaq
Brian Elsbernd - trading volume in the past year for Catalyst Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Restricted Stock Units |
1.07M |
$2.4M |
$2.24 |
Feb 14, 2025 |
Direct |
Common Stock |
|
Common Stock, par value $0.001 per share |
189K |
$422K |
$2.24 |
Feb 14, 2025 |
Direct |
|
|
Options to Purchase Common Stock |
1.1M |
|
|
Nov 26, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.